arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

BiomX Inc.

PHGE

$0.17 ▲ +0.01 (+7.43%) at close

9 Visible periods

24 Metrics

Absolute Benchmarks

Price Chart

Health

Poor

Neutral Absolute basis

auto_awesome

Analytical Summary

On an absolute basis, BiomX Inc. shows mixed fundamentals. Return on Invested Capital remain bright spots. These readings use fixed quality thresholds rather than peer benchmarks, because too few comparable companies are available to rank against.

Market Cap —

Dividend Yield —

Revenue Growth —

Op. Margin —

ROIC 3185.4% ↗

FCF / Share $-16.18 ↘

Trailing P/E 0.0x

Price / Book —

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Aug 7, 2026.

9-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Net Income Profit after all expenses

$-36.20M

↓ -104.2% —

FCF / Share Free cash flow per share

$-16.18

↓ -425.5% —

Long-Term Debt Long-term obligations

$5.40M

↓ -64.0% —

info Signals below are graded against fixed quality thresholds, not peers — peer ranking needs more comparable companies.

trending_up

Bullish Indicators

Return on Invested CapitalReturn on Invested Capital of 3185.4% is excellent on an absolute basis (target > 10%)

warning

Bearish Risks

Interest CoverageInterest Coverage of -2073.30x is weak on an absolute basis (target > 5x)
FCF / Net IncomeFCF / Net Income of 0.73x is caution on an absolute basis (target > 1x)

Health Breakdown

Financial Health ↓

Cash Quality ↓

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Jun 30, 2018 10-K ↗
EPS Growth YoY (%)	1409.5% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-71.2% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	436.8% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	-31.7% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—
Net Income Growth YoY (%)	-104.2% Weak ↓ Weak Declining Year-over-year change in net income	32.3% Excellent ↑ Excellent Improving Year-over-year change in net income	7.6% Fair ↑ Fair Improving Year-over-year change in net income	21.8% Good ↑ Good Improving Year-over-year change in net income	-20.4% Weak ↑ Weak Improving Year-over-year change in net income	-46.3% Weak Weak Year-over-year change in net income	-61.7% Weak Weak Year-over-year change in net income	—	—
FCF Growth YoY (%)	-425.5% Weak ↓ Weak Declining Year-over-year change in free cash flow	25.9% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	-324.9% Weak Weak Year-over-year change in free cash flow	18.6% Good Good Year-over-year change in free cash flow	—	—	—	—	—
EPS CAGR 3Y (%)	185.9% Excellent Excellent Compound annual EPS growth over 3 years	1.9% Caution Caution Compound annual EPS growth over 3 years	—	—	—	—	—	—	—

💰 Are margins durable? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Jun 30, 2018 10-K ↗
Effective Tax Rate (%) (%)	-0.0% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.1% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.1% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.2% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.2% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—
FCF / Net Income (x)	0.73x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	2.09x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	0.82x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.03x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.86x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.85x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.92x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.90x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Jun 30, 2018 10-K ↗
Return on Invested Capital (%)	3185.4% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-184.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-299.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-75.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-57.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-41.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-20.8% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	-23.1% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-717.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-103.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-101.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-59.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-45.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-43.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-24.1% Weak Weak Operating profit relative to total assets Optimal: > 10%	-27.6% Weak Weak Operating profit relative to total assets Optimal: > 10%	—
Return on Common Equity (%) (%)	—	-73.4% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-589%)	—	-134.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-997%)	-76.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-608%)	-52.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-449%)	-24.3% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-262%)	-29.7% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-298%)	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Jun 30, 2018 10-K ↗
Debt to Equity (x)	—	—	1.75x Weak ↑ Weak Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+192%)	0.71x Fair ↑ Fair Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+19%)	0.30x Good Good Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-49%)	—	0.00x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-99%)	—	—
Interest Coverage (x)	-2073.30x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-52.38x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-10.54x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-13.16x Weak Weak Operating income divided by interest expense Optimal: > 5x	-50.73x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	—
Net Debt (USD)	$-4.36M	$-16.86M	$-9.51M	$-16.33M	$-47.69M	$-36.48M	$-71.88M	$-8.60M	$-430.00
Debt / EBITDA (x)	—	—	-0.22x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.57x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.42x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	-0.02x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—

📊 What does each share earn? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Jun 30, 2018 10-K ↗
Basic EPS, GAAP (USD)	$22.19	$1.47	$5.10	$0.95	$1.39	—	—	—	—
Free Cash Flow per Share (USD)	$-16.18	$-3.08	$-4.16	$-0.98	$-1.20	—	—	—	—
Book Value per Share (USD)	$-0.82	$1.33	$0.65	$0.70	$1.60	$2.47	$3.69	$18.55	$0.01
Tangible Book Value per Share (USD)	$-0.82	$1.28	$0.65	$0.70	$1.55	$2.34	$3.69	$18.55	$0.01
Basic Weighted Avg Shares (shares)	1.63M	12.02M	5.13M	29.85M	26.01M	—	—	—	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Jun 30, 2018 10-K ↗
Working Capital (USD)	$-804.00K	$12.25M	$6.46M	$28.94M	$55.59M	$53.51M	$78.31M	$38.25M	$-40.57K
LT Debt (USD)	—	—	$5.40M	$15.00M	$14.41M	—	—	—	—
Total Equity (USD)	$-1.30M	$24.15M	$3.08M	$21.04M	$47.53M	$57.47M	$84.46M	$42.80M	$23.98K

📋 What is driving earnings? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Jun 30, 2018 10-K ↗
Depreciation Expense (USD)	$2.92M	$1.80M	$871.00K	$909.00K	$986.00K	$2.18M	$318.00K	$210.00K	—
Net Income, GAAP (USD)	$-36.20M	$-17.73M	$-26.17M	$-28.32M	$-36.23M	$-30.09M	$-20.56M	$-12.72M	—
Operating Cash Flow (USD)	$-26.39M	$-36.98M	$-21.29M	$-29.09M	$-27.57M	$-24.45M	$-17.58M	$-11.30M	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 9 years · 34 quarters

BiomX Inc.

Analytical Summary

9-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Benchmarks unavailable

Compare PHGE with peers